Skip Navigation

Sexually Transmitted Diseases Data Details

STD-1 Reduce the proportion of adolescents and young adults with Chlamydia trachomatis infections

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
STD Surveillance System (STDSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
7.4 (2008)
Target
6.7
Target-Setting Method
10 percent improvement
Numerator
Number of positive tests among women aged 15 to 24 years who attended family planning clinics in the past 12 months
Denominator
Number tests administered (unsatisfactory tests, indeterminate or inconclusive results, or inadequate specimens are excluded) among women aged 15 to 24 years who attended family planning clinics in the past 12 months
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

Data are collected from regional infertility prevention infrastructure laboratory reports. This measure tracks only tests that are specific for Chlamydia trachomatis infection. The number of positive cases is based on test results from persons routinely screened. Routine screening is defined by each clinic. In some clinics, all patients are universally screened. In others, routine screening is done selectively based on clinical findings or behavioral risk factors.

Chlamydia positivity data on females screened in family planning clinics are included when the number of females aged 15-24 years tested from a state was greater than or equal to 500. The baseline measure is calculated median state-specific positivity. Medians are reported when at least 20 states met the inclusion criteria.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10): 1997.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
STD Surveillance System (STDSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
12.8 (2008)
Target
11.5
Target-Setting Method
10 percent improvement
Numerator
Number of females aged 24 years or younger who enrolled in a National Job Training Program in the past 12 months and tested positive for Chlamydia
Denominator
Number of females aged 24 years or younger who enrolled in a National Job Training Program in the past 12 months and tested positive or negative for Chlamydia
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

Since 1990, approximately 20,000 female National Job Training Program entrants have been screened each year for Chlamydia. This program, administered by the National Job Training Program at more than 100 sites throughout the country, is a job training program for economically-disadvantaged youth aged 16-24 years-old..

Data are limited to entrance exam testing; therefore, no one is included twice. All persons entering the National Job Training Program are required to be tested. .

Chlamydia prevalence data on female National Job Training Program entrants are included when the number of females tested from a state was greater than or equal to 100. The baseline measure is median state-specific prevalence. Medians are reported when at least 20 states met the inclusion criteria.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10): 1997.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
STD Surveillance System (STDSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
7.0 (2008)
Target
6.3
Target-Setting Method
10 percent improvement
Numerator
Number of males aged 24 years or younger who enrolled in a National Job Training Program in the past 12 months and tested positive for Chlamydia
Denominator
Number of males aged 24 years or younger who enrolled in a National Job Training Program in the past 12 months and tested positive or negative for Chlamydia
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

Since 2004, approximately 35,000 male National Job Training Program entrants have been screened each year for Chlamydia. This program, administered by the National Job Training Program at more than 100 sites throughout the country, is a job training program for economically-disadvantaged youth aged 16-24 years-old..

Data are limited to entrance exam testing; therefore, no one is included twice. All persons entering the National Job Training Program are required to be tested.

Chlamydia prevalence data on male National Job Training Program entrants are included when the number of males tested from a state was greater than or equal to 100. The baseline measure is median state-specific prevalence. Medians are reported when at least 20 states met the inclusion criteria.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10): 1997.
STD-3 Increase the proportion of sexually active females aged 24 years and under enrolled in Medicaid plans who are screened for genital Chlamydia infections during the measurement year

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Healthcare Effectiveness Data and Information Set (HEDIS); National Committee for Quality Assurance (NCQA)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
52.7 (2008)
Target
70.9
Target-Setting Method
Projection/trend analysis
Numerator
Number of women 16-20 years of age who were identified as eligible in the denominator and who had at least one test for Chlamydia during the measurement year
Denominator
Number of women 16-20 years of age who were identified as sexually active and who had no more than one gap in enrollment of up to 45 days during the measurement year
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Chlamydia trachomatis infection is the most common bacterial sexually transmitted disease (STD) in the United States. Untreated Chlamydia can progress to pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. The Centers for Disease Control and Prevention (CDC) estimates that every year, undiagnosed and untreated STDs cause at least 24,000 women in the United States to become infertile.

HEDIS is a widely-used set of performance measures in the managed-care industry, developed and maintained by NCQA. Annual data on Chlamydia screening rates, measured by the proportion of sexually active women aged 15-25 who received at least one Chlamydia test in the measurement year, have been collected in HEDIS since 2000. Screening rates for Medicaid health plans became available in 2001. In 2008, the upper age limit was changed from 25 to 24.

Because of the silent nature of Chlamydia infections, routine screening in clinical and non-clinical settings is the cornerstone of effective STD-related infertility prevention. The HEDIS Chlamydia screening measure is a valuable indicator of commercial and Medicaid health plans’ progress toward increasing the proportion of sexually active women under 25 years of age who are screened at least annually for Chlamydia infections. This is especially important, as the majority of Chlamydia infections are reported from the private sector. The HEDIS data set provides information from health maintenance organizations (HMO) and point-of-service plans (POS).

Changes Between HP2010 and HP2020
This objective differs from Healthy People 2010 objective 25-16b in that objective 25-16b addressed Chlamydia screening among women aged 16 to 25 years enrolled in Medicaid care plans. For Healthy People 2020, the upper age limit was reduced to 24 years and the age category was split into two groups: 16 to 20 years and 21 to 24 years. This objective addresses Chlamydia screening among women aged 16 to 20 years enrolled in Medicaid plans.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The target was revised in 2013 from 74.4 percent to 70.9 percent due to a calculation error.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Healthcare Effectiveness Data and Information Set (HEDIS); National Committee for Quality Assurance (NCQA)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
59.4 (2008)
Target
80.0
Target-Setting Method
Projection/trend analysis
Numerator
Number of women 21-24 years of age who were identified as eligible in the denominator and who had at least one test for Chlamydia during the measurement year
Denominator
Number of women 21-24 years of age who were identified as sexually active and who had no more than one gap in enrollment of up to 45 days during the measurement year
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

Chlamydia trachomatis infection is the most common bacterial sexually transmitted disease (STD) in the United States. Untreated Chlamydia can progress to pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. The Centers for Disease Control and Prevention (CDC) estimates that every year, undiagnosed and untreated STDs cause at least 24,000 women in the United States to become infertile.

HEDIS is a widely-used set of performance measures in the managed-care industry, developed and maintained by NCQA. Annual data on Chlamydia screening rates, measured by the proportion of sexually active women aged 15-25 who received at least one Chlamydia test in the measurement year, have been collected in HEDIS since 2000. Screening rates for Medicaid health plans became available in 2001. In 2008, the upper age limit was changed from 25 to 24.

Because of the silent nature of Chlamydia infections, routine screening in clinical and non-clinical settings is the cornerstone of effective STD-related infertility prevention. The HEDIS Chlamydia screening measure is a valuable indicator of commercial and Medicaid health plans’ progress toward increasing the proportion of sexually active women under 25 years of age who are screened at least annually for Chlamydia infections. This is especially important, as the majority of Chlamydia infections are reported from the private sector. The HEDIS data set provides information from health maintenance organizations (HMO) and point-of-service plans (POS).

Changes Between HP2010 and HP2020
This objective differs from Healthy People 2010 objective 25-16b in that objective 25-16b addressed Chlamydia screening among women aged 16 to 25 years enrolled in Medicaid care plans. For Healthy People 2020, the upper age limit was reduced to 24 years and the age category was split into two groups: 16 to 20 years and 21 to 24 years. This objective addresses Chlamydia screening among women aged 21 to 24 years enrolled in Medicaid plans.
STD-4 Increase the proportion of sexually active females aged 24 years and under enrolled in commercial health insurance plans who are screened for genital Chlamydia infections during the measurement year

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Healthcare Effectiveness Data and Information Set (HEDIS); National Committee for Quality Assurance (NCQA)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
40.1 (2008)
Target
61.3
Target-Setting Method
Projection/trend analysis
Numerator
Number of women 16-20 years of age who were identified as eligible in the denominator and who had at least one test for Chlamydia during the measurement year
Denominator
Number of women 16-20 years of age who were identified as sexually active and who had no more than one gap in enrollment of up to 45 days during the measurement year
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Chlamydia trachomatis infection is the most common bacterial sexually transmitted disease (STD) in the United States. Untreated Chlamydia can progress to pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. The Centers for Disease Control and Prevention (CDC) estimates that every year, undiagnosed and untreated STDs cause at least 24,000 women in the United States to become infertile.

HEDIS is a widely-used set of performance measures in the managed-care industry, developed and maintained by NCQA. Annual data on Chlamydia screening rates, measured by the proportion of sexually active women aged 15-25 who received at least one Chlamydia test in the measurement year, have been collected in HEDIS since 2000. Screening rates for Medicaid health plans became available in 2001. In 2008, the upper age limit was changed from 25 to 24.

Because of the silent nature of Chlamydia infections, routine screening in clinical and non-clinical settings is the cornerstone of effective STD-related infertility prevention. The HEDIS Chlamydia screening measure is a valuable indicator of commercial and Medicaid health plans’ progress toward increasing the proportion of sexually active women under 25 years of age who are screened at least annually for Chlamydia infections. This is especially important, as the majority of Chlamydia infections are reported from the private sector. The HEDIS data set provides information from health maintenance organizations (HMO) and point-of-service plans (POS).

Changes Between HP2010 and HP2020
This objective differs from Healthy People 2010 objective 25-16a in that objective 25-16a addressed Chlamydia screening among women aged 16 to 25 years enrolled in commercial health insurance plans. For Healthy People 2020, the upper age limit was reduced to 24 years and the age category was split into two groups: 16 to 20 years and 21 to 24 years. This objective addresses Chlamydia screening among women aged 16 to 20 years enrolled in commercial plans.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The target was revised in 2013 from 65.9 percent to 61.3 percent due to a calculation error.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
Healthcare Effectiveness Data and Information Set (HEDIS); National Committee for Quality Assurance (NCQA)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
43.5 (2008)
Target
74.6
Target-Setting Method
Projection/trend analysis
Numerator
Number of women 21-24 years of age who were identified as eligible in the denominator and who had at least one test for Chlamydia during the measurement year
Denominator
Number of women 21-24 years of age who were identified as sexually active and who had no more than one gap in enrollment of up to 45 days during the measurement year
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

Chlamydia trachomatis infection is the most common bacterial sexually transmitted disease (STD) in the United States. Untreated Chlamydia can progress to pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. The Centers for Disease Control and Prevention (CDC) estimates that every year, undiagnosed and untreated STDs cause at least 24,000 women in the United States to become infertile.

HEDIS is a widely-used set of performance measures in the managed-care industry, developed and maintained by NCQA. Annual data on Chlamydia screening rates, measured by the proportion of sexually active women aged 15-25 who received at least one Chlamydia test in the measurement year, have been collected in HEDIS since 2000. Screening rates for Medicaid health plans became available in 2001. In 2008, the upper age limit was changed from 25 to 24.

Because of the silent nature of Chlamydia infections, routine screening in clinical and non-clinical settings is the cornerstone of effective STD-related infertility prevention. The HEDIS Chlamydia screening measure is a valuable indicator of commercial and Medicaid health plans’ progress toward increasing the proportion of sexually active women under 25 years of age who are screened at least annually for Chlamydia infections. This is especially important, as the majority of Chlamydia infections are reported from the private sector. The HEDIS data set provides information from health maintenance organizations (HMO) and point-of-service plans (POS).

Changes Between HP2010 and HP2020
This objective differs from Healthy People 2010 objective 25-16a in that objective 25-16a addressed Chlamydia screening among women aged 16 to 25 years enrolled in commercial health insurance plans. For Healthy People 2020, the upper age limit was reduced to 24 years and the age category was split into two groups: 16 to 20 years and 21 to 24 years. This objective addresses Chlamydia screening among women aged 21 to 24 years enrolled in commercial plans.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The target was revised in 2013 from 78.3 percent to 74.6 percent due to a calculation error.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Survey of Family Growth (NSFG); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
percent 
Baseline (Year)
4.2 (2006-2010)
Target
3.8
Target-Setting Method
10 percent improvement
Numerator
Number of females aged 15 to 44 years who have ever required treatment for PID
Denominator
Number of females aged 15 to 44 years
Questions Used to Obtain the National Baseline Data

From the 2002 National Survey of Family Growth:

[NUMERATOR:]

Have you ever been treated for an infection in your fallopian tubes, womb, or ovaries, also called a pelvic infection, pelvic inflammatory disease, or P.I.D.?

  1. Yes
  2. No
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

There are no reliable national surveillance systems that measure women requiring treatment for PID. This measure, based on data from NSFG, is used as a proxy.

PID is a subjective diagnosis made by physicians. Laparoscopy is required for a definitive diagnosis of PID. The data from the NSFG are self-reported and therefore may not be accurate, particularly due to the unknown prevalence of asymptomatic or subclinical PID.

More than 50 percent of all preventable infertility among women is a result of STDs, primarily Chlamydia and gonorrhea. Because most infected women and at least one half of infected men have no symptoms or have such mild symptoms that they do not seek medical care, many infections go undetected and are not reported or counted. Untreated Chlamydia and gonorrhea infections can cause severe and costly reproductive and other adverse health consequences, including pelvic inflammatory disease (PID), which can lead to infertility. Between 10-20 percent of females with untreated Chlamydia infections develop PID, and 20 percent of those may become infertile.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The original baseline was revised in 2012 from 4.0 percent to 4.2 percent due to a change in the baseline year from 2006-2008 to 2006-2010. The target was adjusted from 3.6 percent to 3.8 percent to reflect the revised baseline using the original target-setting method.

STD-6 Reduce gonorrhea rates

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
STD Surveillance System (STDSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Bridged-Race Population Estimates for Census 2000 and 2010; Centers for Disease Control and Prevention, National Center for Health Statistics and U.S. Census Bureau (CDC/NCHS and Census)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
279.9 (2008)
Target
251.9
Target-Setting Method
10 percent improvement
Numerator
Number of new reported cases of gonorrhea among females aged 15-44 years in the past 12 months
Denominator
Number of females aged 15-44 years
Data Collection Frequency
Annual
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

Rates are based on individual-level gonorrhea case report data electronically sent to CDC through the National Electronic Telecommunications System for Surveillance (NETSS) and U.S. Census population data. The race categories used in this report were introduced to the NETSS record in 2008. As of 2011, 46 states and the District of Columbia report using the new format. Race and ethnicity will not be displayed until 100% of states report using the new format.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The original baseline was revised in 2013 from 285.0 to 279.9 new cases per 100,000 females aged 15-44 years due to reporting delays. The target was adjusted from 257.0 to 251.9 new cases per 100,000 females aged 15-44 years to reflect the revised baseline using the original target setting method.

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
STD Surveillance System (STDSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Bridged-Race Population Estimates for Census 2000 and 2010; Centers for Disease Control and Prevention, National Center for Health Statistics and U.S. Census Bureau (CDC/NCHS and Census)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
216.5 (2008)
Target
194.8
Target-Setting Method
10 percent improvement
Numerator
Number of new reported cases of gonorrhea among males aged 15-44 years in the past 12 months
Denominator
Number of males aged 15-44 years
Comparable Healthy People 2010 Objective
Not applicable
Methodology Notes

Rates are based on individual-level gonorrhea case report data electronically sent to CDC through the National Electronic Telecommunications System for Surveillance (NETSS) and U.S. Census population data. The race categories used in this report were introduced to the NETSS record in 2008. As of 2011, 46 states and the District of Columbia report using the new format. Race and ethnicity will not be displayed until 100% of states report using the new format.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The original baseline was revised in 2013 from 220.0 to 216.5 new cases per 100,000 males aged 15-44 years due to reporting delays. The target was adjusted from 198.0 to 194.8 new cases per 100,000 males aged 15-44 years to reflect the revised baseline using the original target setting method.

STD-7 Reduce sustained domestic transmission of primary and secondary syphilis

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
STD Surveillance System (STDSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Bridged-Race Population Estimates for Census 2000 and 2010; Centers for Disease Control and Prevention, National Center for Health Statistics and U.S. Census Bureau (CDC/NCHS and Census)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
1.4 (2008)
Target
1.3
Target-Setting Method
10 percent improvement
Numerator
Number of new reported cases of primary and secondary syphilis among females in the past 12 months
Denominator
Number of females
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Rates are based on individual-level case report data of females with primary and secondary syphilis electronically sent to CDC through the National Electronic Telecommunications System for Surveillance (NETSS) and U.S. Census population data. The race categories used in this report were introduced to the NETSS record in 2008. As of 2011, 46 states and the District of Columbia report using the new format. Race and ethnicity will not be displayed until 100% of states report using the new format.

Changes Between HP2010 and HP2020
This objective differs from Healthy People 2010 objective 25-3 in that objective 25-3 addressed syphilis transmission among all persons. Healthy People 2020 measures syphilis transmission separately for males and females. This objective addresses syphilis among females.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The original baseline was revised in 2013 from 1.5 new cases per 100,000 females to 1.4 new cases per 100,000 females due to reporting delays. The target was adjusted from 1.4 new cases per 100,000 females to 1.3 new cases per 100,000 females to reflect the revised baseline using the original target setting method. The objective text was revised from "Reduce sustained domestic transmission of primary and secondary syphilis among females" to "Reduce domestic transmission of primary and secondary syphilis among females".

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
STD Surveillance System (STDSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
Bridged-Race Population Estimates for Census 2000 and 2010; Centers for Disease Control and Prevention, National Center for Health Statistics and U.S. Census Bureau (CDC/NCHS and Census)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
7.4 (2008)
Target
6.7
Target-Setting Method
10 percent improvement
Numerator
Number of new reported cases of primary and secondary syphilis among males in the past 12 months
Denominator
Number of males
Comparable Healthy People 2010 Objective
Adapted from HP2010 objective
Methodology Notes

Rates are based on individual-level case report data of males with primary and secondary syphilis electronically sent to CDC through the National Electronic Telecommunications System for Surveillance (NETSS) and U.S. Census population data. The race categories used in this report were introduced to the NETSS record in 2008. As of 2011, 46 states and the District of Columbia report using the new format. Race and ethnicity will not be displayed until 100% of states report using the new format.

Changes Between HP2010 and HP2020
This objective differs from Healthy People 2010 objective 25-3 in that objective 25-3 addressed syphilis transmission among all persons. Healthy People 2020 measures syphilis transmission separately for males and females. This objective addresses syphilis among males.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The original baseline was revised in 2013 from 7.6 new cases per 100,000 males to 7.4 new cases per 100,000 males due to reporting delays. The target was adjusted from 6.8 new cases per 100,000 males to 6.7 new cases per 100,000 males to reflect the revised baseline using the original target setting method. The objective text was revised from "Reduce sustained domestic transmission of primary and secondary syphilis among males" to "Reduce domestic transmission of primary and secondary syphilis among males".

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
STD Surveillance System (STDSS); Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (CDC/NCHHSTP)
National Vital Statistics System-Natality (NVSS-N); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
Yes
Measure
per 100,000 
Baseline (Year)
10.7 (2008)
Target
9.6
Target-Setting Method
10 percent improvement
Numerator
Number of new reported cases of congenital syphilis in the past 12 months
Denominator
Number of live births
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

Pregnant women who are infected with syphilis can transmit the infection to the fetus causing congenital syphilis (CS) with serious adverse outcomes of the pregnancy in at least 50% of the cases. Elimination of congenital syphilis would contribute importantly to reduction of lost pregnancies, preterm/low birthweight infants and prenatal death.

Although the numbers and rates of CS have been declining in the United States, there is a danger of a resurgence should syphilis recur among heterosexual populations. Yet, unlike many neonatal infections, this is a preventable disease which could be eliminated through effective antenatal screening and treatment of infected pregnant women.

A minimum of 500 valid test results by gender and subpopulation is recommended to derive reliable estimates for this measure. Some clinics may not collect all U.S. Census-defined race and/or ethnicity data categories. Data are based on CDC congenital syphilis (CS) case investigation and report, Form 73.126.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch

The original baseline was revised in 2013 from 10.1 new cases per 100,000 live births to 10.7 new cases per 100,000 live births due to reporting delays. The target was adjusted from 9.1 new cases per 100,000 live births to 9.6 new cases per 100,000 live births to reflect the revised baseline using the original target setting method.

STD-9 (Developmental) Reduce the proportion of females with human papillomavirus (HPV) infection

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health and Nutrition Examination Survey (NHANES); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
National Health Interview Survey (NHIS)
Changed Since the Healthy People 2020 Launch
No
Measure
*** Missing *** 
Numerator
Number of females aged 14 to 24 years with detectable HPV type 6 or 11 DNA
Denominator
Number of females aged 14 to 24 years
Comparable Healthy People 2010 Objective
Not applicable

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health and Nutrition Examination Survey (NHANES); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
National Health Interview Survey (NHIS)
Changed Since the Healthy People 2020 Launch
No
Measure
*** Missing *** 
Numerator
Number of females aged 14 to 24 years with detectable  HPV types 16 or 18 DNA
Denominator
Number of females aged 14 to 24 years
Comparable Healthy People 2010 Objective
Not applicable

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health and Nutrition Examination Survey (NHANES); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
*** Missing *** 
Numerator
Number of females aged 14 to 49 years with a positive result from 43 HPV types
Denominator
Number of females aged 14 to 49
Comparable Healthy People 2010 Objective
Retained from HP2010 objective

About the Data

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

National Data Source
National Health and Nutrition Examination Survey (NHANES); Centers for Disease Control and Prevention, National Center for Health Statistics (CDC/NCHS)
Changed Since the Healthy People 2020 Launch
No
Measure
percent 
Baseline (Year)
10.5 (2005-2008)
Target
9.5
Target-Setting Method
10 percent improvement
Numerator
Number of persons aged 20 to 29 years who test positive for herpes simplex virus type 2 (HSV-2)
Denominator
Number of persons aged 20 to 29 years
Comparable Healthy People 2010 Objective
Retained from HP2010 objective
Methodology Notes

This measure tracks the proportion of persons aged 20 to 29 years with a positive laboratory test result for herpes simplex virus, type 2, as measured by NHANES.

References

Additional resources about the objective.

  1. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report 46 (RR-10): 1997.